Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_3
1
17%
Ph phase_1
3
50%
Ph not_applicable
1
17%
Ph phase_2
1
17%

Phase Distribution

3

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (50.0%)
Phase 21 (16.7%)
Phase 31 (16.7%)
N/A1 (16.7%)

Trials by Status

terminated117%
completed467%
recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_3

Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis

NCT07164183
completedphase_1

Trial of Indole-3-Carbinol and Silibinin

NCT03687073
terminatedphase_2

Indole-3-Carbinol Effects on Estrogen Metabolism

NCT00988845
completedphase_1

Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer

NCT00033345
completednot_applicable

Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate Cancer

NCT00607932
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07164183Phase 3

Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis

Recruiting
NCT03687073Phase 1

Trial of Indole-3-Carbinol and Silibinin

Completed
NCT00988845Phase 2

Indole-3-Carbinol Effects on Estrogen Metabolism

Terminated
NCT00033345Phase 1

Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer

Completed
NCT00607932Not Applicable

Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate Cancer

Completed
NCT00100958Phase 1

Indole-3-Carbinol in Preventing Cancer in Healthy Participants

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6